Intuitive Surgical, Inc. Payments for Repurchase of Common Stock
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- Intuitive Surgical, Inc. payments for repurchase of common stock for the quarter ending 2026-06-30 was $320.30M, a 76.96% increase year-over-year.
- Intuitive Surgical, Inc. payments for repurchase of common stock for the quarter ending 2026-03-31 was $1.12B.
- Intuitive Surgical, Inc. payments for repurchase of common stock for the quarter ending 2025-12-31 was $201.00M.
- Intuitive Surgical, Inc. payments for repurchase of common stock for the quarter ending 2025-09-30 was $1.91B.
- Intuitive Surgical, Inc. payments for repurchase of common stock for fiscal 2025 was $2.30B.
- Intuitive Surgical, Inc. payments for repurchase of common stock for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- Intuitive Surgical, Inc. payments for repurchase of common stock for fiscal 2023 was $416.30M, a 84.03% decline from fiscal 2022.
- Intuitive Surgical, Inc. payments for repurchase of common stock for fiscal 2022 was $2.61B.
| Period end | Payments for Repurchase of Common Stock 3 month | Payments for Repurchase of Common Stock 12 month |
|---|---|---|
| 2026-06-30 | $320.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-21 | $3.56B derived: sum of 4 quarters · filed 2026-07-21 |
| 2026-03-31 | $1.12B 10-Q · filed 2026-04-22 | $3.42B derived: sum of 4 quarters · filed 2026-07-21 |
| 2025-12-31 | $201.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-03 | $2.30B 10-K · filed 2026-02-03 |
| 2025-09-30 | $1.91B derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-22 | $2.09B derived: sum of 4 quarters · filed 2026-07-21 |
| 2025-06-30 | $181.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-21 | $181.00M derived: sum of 4 quarters · filed 2026-07-21 |
| 2025-03-31 | $0.00 10-Q · filed 2026-04-22 | $0.00 derived: sum of 4 quarters · filed 2026-04-22 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-03 | $0.00 10-K · filed 2026-02-03 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-22 | $66.30M derived: sum of 4 quarters · filed 2026-02-03 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-23 | $66.30M derived: sum of 4 quarters · filed 2026-02-03 |
| 2024-03-31 | $0.00 10-Q · filed 2024-04-19 | $66.30M derived: sum of 4 quarters · filed 2026-02-03 |
| 2023-12-31 | $66.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-03 | $416.30M 10-K · filed 2026-02-03 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-18 | $1.35B derived: sum of 4 quarters · filed 2025-01-31 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-19 | $2.35B derived: sum of 4 quarters · filed 2025-01-31 |
| 2023-03-31 | $350.00M 10-Q · filed 2024-04-19 | $2.85B derived: sum of 4 quarters · filed 2025-01-31 |
| 2022-12-31 | $1.00B derived: 10-K 12 month − 10-Q 9 month · filed 2025-01-31 | $2.61B 10-K · filed 2025-01-31 |
| 2022-09-30 | $1.00B derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-20 | $1.61B derived: sum of 4 quarters · filed 2024-01-31 |
| 2022-06-30 | $500.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-24 | $606.60M derived: sum of 4 quarters · filed 2024-01-31 |
| 2022-03-31 | $106.50M 10-Q · filed 2023-04-20 | $106.50M derived: sum of 4 quarters · filed 2024-01-31 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-01-31 | $0.00 10-K · filed 2024-01-31 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-21 | $34.30M derived: sum of 4 quarters · filed 2023-02-10 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-22 | $34.30M derived: sum of 4 quarters · filed 2023-02-10 |
| 2021-03-31 | $0.00 10-Q · filed 2022-04-22 | $34.30M derived: sum of 4 quarters · filed 2023-02-10 |
| 2020-12-31 | $34.30M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-10 | $134.30M 10-K · filed 2023-02-10 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-20 | $100.00M derived: sum of 4 quarters · filed 2022-02-03 |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-21 | $169.50M derived: sum of 4 quarters · filed 2022-02-03 |
| 2020-03-31 | $100.00M 10-Q · filed 2021-04-21 | $369.50M derived: sum of 4 quarters · filed 2022-02-03 |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-03 | $269.50M 10-K · filed 2022-02-03 |
| 2019-09-30 | $69.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-19 | $269.50M derived: sum of 4 quarters · filed 2021-02-10 |
| 2019-06-30 | $200.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-23 | $200.00M derived: sum of 4 quarters · filed 2021-02-10 |
| 2019-03-31 | $0.00 10-Q · filed 2020-04-17 | $0.00 derived: sum of 4 quarters · filed 2021-02-10 |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-10 | $0.00 10-K · filed 2021-02-10 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-18 | $274.00M derived: sum of 4 quarters · filed 2020-02-07 |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-22 | $274.00M derived: sum of 4 quarters · filed 2020-02-07 |
| 2018-03-31 | $0.00 10-Q · filed 2018-04-18 | $274.00M derived: sum of 4 quarters · filed 2020-02-07 |
| 2017-12-31 | $274.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-07 | $2.27B 10-K · filed 2020-02-07 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-22 | $2.03B derived: sum of 4 quarters · filed 2019-02-04 |
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-20 | $2.03B derived: sum of 4 quarters · filed 2019-02-04 |
| 2017-03-31 | $2.00B 10-Q · filed 2018-04-18 | $2.03B derived: sum of 4 quarters · filed 2019-02-04 |
| 2016-12-31 | $34.40M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-04 | $42.50M 10-K · filed 2019-02-04 |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-20 | $92.30M derived: sum of 4 quarters · filed 2018-02-02 |
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-21 | $127.80M derived: sum of 4 quarters · filed 2018-02-02 |
| 2016-03-31 | $8.10M 10-Q · filed 2017-04-19 | $182.10M derived: sum of 4 quarters · filed 2018-02-02 |
| 2015-12-31 | $84.20M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-02 | $183.70M 10-K · filed 2018-02-02 |
| 2015-09-30 | $35.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-19 | $99.50M derived: sum of 4 quarters · filed 2017-02-06 |
| 2015-06-30 | $54.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-20 | $64.00M derived: sum of 4 quarters · filed 2017-02-06 |
| 2015-03-31 | $9.70M 10-Q · filed 2016-04-19 | $1.01B derived: sum of 4 quarters · filed 2017-02-06 |
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-06 | $1.00B 10-K · filed 2017-02-06 |
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-21 | $1.00B derived: sum of 4 quarters · filed 2016-02-02 |
| 2014-06-30 | $1.00B derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-22 | $1.69B derived: sum of 4 quarters · filed 2016-02-02 |
| 2014-03-31 | $0.00 10-Q · filed 2015-04-22 | $963.40M derived: sum of 4 quarters · filed 2016-02-02 |
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-02 | $1.11B 10-K · filed 2016-02-02 |
| 2013-09-30 | $693.80M 10-Q · filed 2013-10-18 | $1.16B derived: sum of 4 quarters · filed 2015-02-06 |
| 2013-06-30 | $269.60M 10-Q · filed 2013-07-22 | $638.30M derived: sum of 4 quarters · filed 2015-02-06 |
| 2013-03-31 | $145.70M 10-Q · filed 2014-04-25 | $383.90M derived: sum of 4 quarters · filed 2015-02-06 |
| 2012-12-31 | $53.20M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-06 | $238.30M 10-K · filed 2015-02-06 |
| 2012-09-30 | $169.80M 10-Q · filed 2013-10-18 | $185.00M derived: sum of 4 quarters · filed 2014-02-03 |
| 2012-06-30 | $15.20M 10-Q · filed 2013-07-22 | $196.30M derived: sum of 4 quarters · filed 2014-02-03 |
| 2012-03-31 | $0.00 10-Q · filed 2012-04-19 | $320.20M derived: sum of 4 quarters · filed 2014-02-03 |
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-03 | $331.80M 10-K · filed 2014-02-03 |
| 2011-09-30 | $181.10M 10-Q · filed 2012-10-18 | $471.50M derived: sum of 4 quarters · filed 2013-02-04 |
| 2011-06-30 | $139.10M 10-Q · filed 2012-07-23 | $349.30M derived: sum of 4 quarters · filed 2013-02-04 |
| 2011-03-31 | $11.60M 10-Q · filed 2012-04-19 | $210.20M derived: sum of 4 quarters · filed 2013-02-04 |
| 2010-12-31 | $139.70M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-04 | $198.60M 10-K · filed 2013-02-04 |
| 2010-09-30 | $58.90M 10-Q · filed 2011-10-19 | $58.90M derived: sum of 4 quarters · filed 2012-02-06 |
| 2010-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2011-07-20 | $0.00 derived: sum of 4 quarters · filed 2012-02-06 |
| 2010-03-31 | $0.00 10-Q · filed 2010-04-20 | $0.00 derived: sum of 4 quarters · filed 2012-02-06 |
| 2009-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-06 | $150.00M 10-K · filed 2012-02-06 |
| 2009-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2010-10-20 | $150.00M derived: sum of 4 quarters · filed 2011-02-01 |
| 2009-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2010-07-23 | $150.00M derived: sum of 4 quarters · filed 2011-02-01 |
| 2009-03-31 | $150.00M 10-Q · filed 2010-04-20 | |
| 2008-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-01 | $0.00 10-K · filed 2011-02-01 |
| 2008-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2009-10-21 | |
| 2007-12-31 | $0.00 10-K · filed 2010-01-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Edwards Lifesciences Corp (EW) | United States | $49.409B | 51.96 |
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |